Home 禄 Business 禄 Manufacturing
Bayer to cooperate on cancer
BAYER AG said yesterday it had entered into five projects with scientists in Singapore to work on earlier diagnosis and treatment of cancers that are most prevalent in Asia.
Senior researchers at the German pharmaceutical giant also said they had identified five compounds which they hope can fight liver, stomach and colorectal cancer.
"Five compounds that have survived early identification fit into these three cancers with high prevalence in Asia," Ludger Dinkelborg, head of Bayer's diagnostic imaging research, said in an interview.
"We can't predict if one of the five will make it. Of course, we want to make it to market, which is why we are here."
Cancer is a leading cause of mortality worldwide, killing 7.4 million people in 2004. Topping the list is lung cancer, which killed 1.3 million people. The World Health Organisation projects there will be 12 million cancer deaths worldwide in 2030.
Senior researchers at the German pharmaceutical giant also said they had identified five compounds which they hope can fight liver, stomach and colorectal cancer.
"Five compounds that have survived early identification fit into these three cancers with high prevalence in Asia," Ludger Dinkelborg, head of Bayer's diagnostic imaging research, said in an interview.
"We can't predict if one of the five will make it. Of course, we want to make it to market, which is why we are here."
Cancer is a leading cause of mortality worldwide, killing 7.4 million people in 2004. Topping the list is lung cancer, which killed 1.3 million people. The World Health Organisation projects there will be 12 million cancer deaths worldwide in 2030.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔$粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.